Brought to you by WBIW News and Network Indiana
Last updated on Friday, February 29, 2008
(INDIANAPOLIS) - The U.S. Food and Drug Administration is delaying approval of a longer-lasting version of Eli Lilly’s top-selling drug Zyprexa.
Regulators want to learn more about why some patients experienced symptoms described as excessive sedation.
Some patients wind up in a coma-like state for hours after taking the drug. Others were drowsy or had slurred speech.
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com
© Ad-Venture Media, Inc. All Rights Reserved.